Inventor · disambiguated record
Vincent Mikol
Also filed as: MIKOL VINCENT
21 granted patents·17 pending applications·379 citations·filing 2007–2024
95Inventor score
Top patents by PatentIndex Score
38 records- 0195US8614299B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideBAURIN NICOLAS·Filed 2010·Granted Dec 24, 2013·56 cites·27 claims
- 0294US9221917B2Dual variable region antibody-like binding proteins having cross-over binding region orientationBAURIN NICOLAS·Filed 2013·Granted Dec 29, 2015·23 cites·21 claims
- 0394US9181349B2Dual variable region antibody-like binding proteins having cross-over binding region orientationBAURIN NICOLAS·Filed 2013·Granted Nov 10, 2015·29 cites·26 claims
- 0494US8388965B2Antibodies that bind IL-4 and/or IL-13 and their usesRAO ERCOLE·Filed 2008·Granted Mar 5, 2013·56 cites·21 claims
- 0594US8153765B2Anti-CD38 antibodies for the treatment of cancerPARK PETER U·Filed 2007·Granted Apr 10, 2012·164 cites·30 claims
- 0693US11453727B2Antibodies that bind IL-4 and/or IL-13 and their usesSANOFI SA·Filed 2020·Granted Sep 27, 2022·2 cites·12 claims
- 0793US9738728B2Antibodies that bind IL-4 and/or IL-13 and their usesSANOFI SA·Filed 2013·Granted Aug 22, 2017·11 cites·26 claims
- 0892US9732162B2Antibodies that bind IL-4 and/or IL-13 and their usesSANOFI SA·Filed 2013·Granted Aug 15, 2017·8 cites·37 claims
- 0991US2025313651A1Antibodies that bind il-4 and/or il-13 and their usesSANOFI SA·Filed 2024·Application pending·0 cites
- 1087US2025216392A1Novel anti-cd38 antibodies for the treatment of cancerSANOFI AVENTIS US LLC·Filed 2024·Application pending·0 cites
- 1186US10759871B2Antibodies that bind IL-4 and/or IL-13 and their usesSANOFI SA·Filed 2017·Granted Sep 1, 2020·1 cites·6 claims
- 1284US8647622B2Humanized anti-CXCR5 antibodies, derivatives thereof and their useLEE RENATA·Filed 2008·Granted Feb 11, 2014·9 cites·9 claims
- 1383US8852593B2Antagonist antibodies and their fab fragments against GPVI and uses thereofBAURIN NICOLAS·Filed 2010·Granted Oct 7, 2014·8 cites·8 claims
- 1482US2023235088A1Antibodies that bind il-4 and/or il-13 and their usesSANOFI SA·Filed 2022·Application pending·0 cites
- 1580US10112991B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideSANOFI SA·Filed 2016·Granted Oct 30, 2018·2 cites·30 claims
- 1680US8668910B2Antibodies that specifically bind to the EphA2 receptorBOUCHARD HERVE·Filed 2010·Granted Mar 11, 2014·5 cites·25 claims
- 1776US9382312B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideSANOFI SA·Filed 2013·Granted Jul 5, 2016·2 cites·26 claims
- 1876US2022073629A1Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their UsesSANOFI SA·Filed 2021·Application pending·0 cites
- 1975US9676864B2Antibodies that specifically bind to the EphA2 receptorSANOFI SA·Filed 2014·Granted Jun 13, 2017·2 cites·19 claims
- 2073US2021189011A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationSANOFI SA·Filed 2020·Application pending·0 cites
- 2172US2020408765A1Novel anti-cd38 antibodies for the treatment of cancerSANOFI SA·Filed 2020·Application pending·0 cites
- 2271US8980262B2Humanized anti-CXCR5 antibodies, derivatives thereof and their useSANOFI SA·Filed 2013·Granted Mar 17, 2015·1 cites·23 claims
- 2365US2018155450A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationSANOFI SA·Filed 2017·Application pending·0 cites
- 2462US2018100019A1Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their UseSANOFI SA·Filed 2018·Application pending·0 cites
- 2560US9243067B2Humanized anti-CXCR5 antibodies, derivatives thereof and their useSANOFI SA·Filed 2013·Granted Jan 26, 2016·0 cites·9 claims
- 2660US9228019B2Humanized anti-CXCR5 antibodies, derivatives thereof and their useSANOFI SA·Filed 2013·Granted Jan 5, 2016·0 cites·9 claims
- 2760US9175087B2Humanized anti-CXCR5 antibodies, derivatives thereof and their useSANOFI SA·Filed 2013·Granted Nov 3, 2015·0 cites·11 claims
- 2860US2016200811A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationSANOFI SA·Filed 2015·Application pending·0 cites
- 2960US2017343550A1Novel anti-cd38 antibodies for the treatment of cancerSANOFI SA·Filed 2017·Application pending·0 cites
- 3060US2012251541A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationBAURIN NICOLAS·Filed 2012·Application pending·0 cites
- 3160US2019119365A1Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideSANOFI SA·Filed 2018·Application pending·0 cites
- 3259US9815902B2Humanized anti-CXCR5 antibodies, derivatives thereof and their usesSANOFI SA·Filed 2016·Granted Nov 14, 2017·0 cites·8 claims
- 3359US2013209469A1Antibodies that bind il-4 and/or il-13 and their usesRAO ERCOLE·Filed 2013·Application pending·0 cites
- 3457US9441040B2Antagonist antibodies and their fab fragments against GPVI and uses thereofSANOFI SA·Filed 2014·Granted Sep 13, 2016·0 cites·15 claims
- 3555US2012156218A1Novel anti-cd38 antibodies for the treatment of cancerPARK PETER U·Filed 2012·Application pending·0 cites
- 3650US2011150903A1Fgf-r4 receptor-specific antagonistsSANOFI AVENTIS·Filed 2009·Application pending·0 cites
- 3744US2014335102A1In silico affinity maturationSANOFI SA·Filed 2012·Application pending·0 cites
- 3838US2012276124A1Maytansinoids and the use of said maytansinoids to prepare conjugates with an antibodyBOUCHARD HERVE·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vincent Mikol files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →